Migraine Resource Network is a comprehensive educational initiative for clinicians seeking current and emerging information on migraine headache. Our mission is to provide ongoing medical education that embodies evidence-based scientific data, current treatment strategies, and the insightful knowledge of expert faculty. Our goal is to support your ongoing dedication to optimizing treatment outcomes for your patients.

Skip to content

Migraine Resource Network

You are here: Home Continuing Ed Migraine 101 (Accredited)

You need to be logged in to continue.
Please Log In or Register.

You can no longer receive credit for taking this course

Diagnosis & Assessment of Menstrual Migraine

Release Date: February 27, 2009
Expiration Date: February 27, 2010



Women can experience migraine throughout their lives, but migraine typically occurs with greater incidence during the reproductive years. Fluctuations in sex hormones may be a primary contributing factor.  It is often difficult for practitioners to determine if the migraine is related to menses. A patient diary is considered an essential tool to help identify signs and symptoms of the migraine and patterns of occurrence which are then correlated to the cyclic onset of the menstrual period. Depending on time of cycle onset, the migraine may be classified as pure or menstrual related. These menstrual-related or pure menstrual migraines have new and dedicated diagnostic codes that support their unique characteristics.

Dr. Hutchinson provides a detailed presentation on best practice assessment and diagnosis of migraine characterized by its relationship to menses, provides the new designated diagnostic codes for classification of menstrual-related and pure menstrual migraine, and offers several case examples that a practitioner may typically encounter in the clinical practice setting.

Target Audience

This activity is designed for physicians and other allied healthcare professionals involved in the management of migraine.

Learning Objectives

After completion of this educational activity, participants will be able to:

  • Differentiate characteristics of pure menstrual migraine from those associated with menstrual-related migraine
  • Correlate estrogen fluctuation with onset of menstrual migraine
  • Recognize the value of the patient diary or calendar in the assessment, classification, and diagnosis of menstrual migraine
  • Contrast and compare ICD-II criteria for application in assignment of diagnostic codes for migraine

General Information

This activity is eligible for credit through February 27, 2010. After this date, this activity will expire and no further credit will be awarded.

Expected time to complete this activity as designed: 30 minutes

There are no fees for participating in this activity. All participants must complete the Activity Evaluation Form. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates may be printed immediately after successfully completing the online self-assessment and evaluation.

Faculty Biography

Susan L. Hutchinson, MD, is board certified in family practice and has a subspecialty in headache. She is director and founder of the Orange County Migraine & Headache Center in Irvine, California. She is also an associate clinical professor in the department of family medicine at UC-Irvine Medical Center. She concentrates on the management of migraine and mood disorders with a special interest on the relationship of both conditions to hormones. Dr. Hutchinson is a national speaker on both migraines and depression and was awarded the National Headache Foundation Lectureship Award in February 2003 in recognition of her contribution to headache education. She was selected as a Physician of Excellence by the Orange County Medical Association in January 2007. In recent years, she has coauthored numerous journal articles and chapters on the subject of migraine.


Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of MediCom Worldwide, Inc. and Medical Learning Solutions. MediCom Worldwide, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for .5 contact hour(s) of Continuing Education Credit. Universal Activity Number: 827-000-09-225-H01-P Knowledge-based CPE activity.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.

Faculty Disclosure

Dr. Hutchinson has received honoraria related to formal advisory activities from Endo Pharmaceuticals, Forest Laboratories, Inc., GlaxoSmithKline, and NuPathe Inc. She has received honoraria related to speakers’ bureau activities from Endo, Forest, GSK, and Merck & Co., Inc.

Planner and Provider Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, executive director; Norma Jean Talley, manager, professional education; and Ruth Widmer, medical editor, have nothing to disclose.

Off-Label/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Hutchinson indicated that her presentation would not include the discussion of unlabeled uses fo commercial products or investigational products not yet approved by the FDA for any use in the United States.

Conflict of Interest Resolution

To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

This activity is supported by an educational grant from Endo Pharmaceuticals.

©2009 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067. No portion of this material may be copied or duplicated without written permission of MediCom.

You need to be logged in to continue.
Please Log In or Register.